The second group consists of tumors that have either tested positive for the human epidermal growth factor receptor 2 (HER2) with or without ER and PR positivity, whereas the third one is called triple-negative breast cancer (TNBC), since these types of tumors lack expression of all three receptors (ER, PR, HER2) [7]. This evidence concerns the gene PGR and triple-negative breast carcinoma.